XML 58 R46.htm IDEA: XBRL DOCUMENT v3.23.2
ACQUISITIONS AND LICENSING AGREEMENTS - 2023 Acquisition, Narrative (Details) - USD ($)
1 Months Ended 5 Months Ended
Jun. 30, 2023
Jan. 17, 2023
Jul. 31, 2023
Jan. 31, 2023
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Asset Acquisition And Business Combination [Line Items]                
Goodwill $ 4,540,000,000       $ 4,540,000,000   $ 4,507,000,000 $ 4,586,000,000
Johnson & Johnson Vision, Blink Product Line Acquisition | Subsequent Event                
Asset Acquisition And Business Combination [Line Items]                
Payment to acquire business, asset acquisition     $ 107,000,000          
XIIDRA® and Certain Other Ophthalmology Assets Acquisition                
Asset Acquisition And Business Combination [Line Items]                
Expected up-front payment 1,750,000,000              
XIIDRA® and Certain Other Ophthalmology Assets Acquisition | Forecast                
Asset Acquisition And Business Combination [Line Items]                
Potential milestone obligation (up to)           $ 750,000,000    
AcuFocus, Inc. Acquisition                
Asset Acquisition And Business Combination [Line Items]                
Up-front payment   $ 35,000,000            
Payment to acquire business       $ 31,000,000        
Purchase price, repayment term   18 months            
Contingent consideration liability   $ 5,000,000            
Inventories, net 4,000,000       4,000,000      
Prepaid expenses and other current assets 4,000,000       4,000,000      
Intangibles, net 28,000,000       28,000,000      
Goodwill 2,000,000       2,000,000      
Deferred tax assets, net 2,000,000       2,000,000      
Property, plant and equipment, net 1,000,000       1,000,000      
Accounts payable 1,000,000       1,000,000      
Accrued and other current liabilities $ 1,000,000       1,000,000      
Measurement period adjustments, deferred tax assets         6,000,000      
Measurement period adjustments, goodwill         $ 6,000,000